@article{article, title  = {{Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension}},

 publisher = {{Wiley}},

 url = {{http://eprints.whiterose.ac.uk/152862/ }},

 year = {{-0001}},

 month = {{11}},

 author = {{Cork MJ and Thaçi D and Eichenfield LF and Arkwright PD and Hultsch T and Davis JD and Zhang Y and Zhu X and Chen Z and Li M and Ardeleanu M et al}},

 doi = {{10.1111/bjd.18476}},

 journal = {{British Journal of Dermatology}},

 note = {{Accessed on 2024/12/22}}}